Synthesis and pharmacological properties of some new 3-(2-N,N-dialkylaminoethyl)-pyrido [2,3-d]-pyrymidin-4-ones. 1994

T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
Institute of Organic Chemistry and Technology, Cracow University of Technology, Kraków.

The following new derivatives of pyrido [2,3-d]-pyrimidin-4(3H)-one were synthesized: 3-(2-N,N-dimethylaminoethyl), 3-(2-N-pyrolidynylethyl), 3-(2-piperidinylethyl) and 3-(2-N-morpholidinylethyl). Their chemical structures were confirmed by MS, IR and 1H NMR spectroscopic data. Newly synthesized compounds were investigated pharmacologically for their central properties in mice and rats. It was shown that compound [III] showed anxiolytic action in the four-plate test and two compounds produced analgesic effects in mice.

UI MeSH Term Description Entries
D008297 Male Males
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
November 1975, Arzneimittel-Forschung,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
March 2009, European journal of medicinal chemistry,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
February 1984, Il Farmaco; edizione scientifica,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
January 1974, Acta poloniae pharmaceutica,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
September 1988, Il Farmaco; edizione scientifica,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
February 2009, Molecular diversity,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
October 2020, ACS omega,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
October 1996, Farmaco (Societa chimica italiana : 1989),
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
January 2000, Die Pharmazie,
T Kowalska, and P Kowalski, and K Rutkowski, and M Woźniak, and Z Kleinrok, and E Jagiełło-Wójtowicz, and G Szurska, and A Chodkowska
December 1972, The Journal of organic chemistry,
Copied contents to your clipboard!